SYDNEY, Aug. 6, 2024 /PRNewswire/ — CrowdProperty Australia’s real estate debt investment fund has achieved a ‘favourable’ 3.75-star rating from SQM Research. This rating signifies the fund’s “moderate potential to outperform over the medium-to-long term” and makes it a strong candidate for inclusion on most approved product lists (APLs). In awarding a 3.75-star ‘favourable’ rating, the […]
Category Archives: Pr Newswire
23 Toyota Group companies adopt OutSystems as their enterprise low-code application development platform SINGAPORE, Aug. 6, 2024 /PRNewswire/ — OutSystems, a global leader transforming how companies innovate through software, today celebrates ten years of successful digital transformation with Toyota Motor Corporation, one of the world’s leading automakers. This partnership with OutSystems is a cornerstone of […]
TOKYO, Aug. 6, 2024 /PRNewswire/ — Ricoh and its affiliates have been awarded the esteemed ‘Gold Provider’ Partner status in the Asia-Pacific region by Cisco, a worldwide leader in networking and security, marking a new chapter in the long-standing partnership between the two companies. This accolade, which was awarded following a comprehensive evaluation, where Ricoh […]
AeC delivers top-notch customer experience (CX) services, enhances productivity, and fosters a customer-centric approach in the Brazilian industry by leveraging its highly advanced CX management (CXM) tools. SAN ANTONIO, Aug. 6, 2024 /PRNewswire/ — Frost & Sullivan recently researched the CXM industry and, based on its findings, recognizes AeC with the 2024 Brazil Company of the Year Award. […]
Pr Newswire
TRxADE Health, Inc. Announces New Addition and Changes to Scienture, LLC’s Executive Leadership Team
05
Aug
Aug
TAMPA, FL and COMMACK, NY, Aug. 05, 2024 (GLOBE NEWSWIRE) — TRxADE Health, Inc. (“TRxADE”) (NASDAQ: MEDS) and Scienture, LLC (“Scienture”), a wholly owned subsidiary of TRxADE, today announced the appointment of Narasimhan Mani, Ph.D., MBA as Scienture’s President. Shankar Hariharan, Ph.D., the current President and CEO, will be CEO of Scienture. Rahul Surana, Ph.D., […]
05
Aug
Aug
LAKEWOOD, Colo., Aug. 05, 2024 (GLOBE NEWSWIRE) — Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its first fiscal quarter (“1Q25”) ended June 30, 2024 (amounts in thousands). First quarter FY 2025 compared to first quarter FY 2024: […]
Pr Newswire
Design Therapeutics Announces Second Quarter 2024 Financial Results and Reviews Near-term Milestones for GeneTAC™ Portfolio
05
Aug
Aug
Friedreich Ataxia (FA) and Fuchs Endothelial Corneal Dystrophy (FECD) Programs on Track and Advancing Toward Clinical Trials Active Research Pipeline with Programs Progressing in Myotonic Dystrophy Type-1 (DM1) and Huntington’s Disease (HD) Cash and Securities of $261.0 Million Supports Operations Through Potentially Four Clinical Proof-of-Concept Data Sets CARLSBAD, Calif., Aug. 05, 2024 (GLOBE NEWSWIRE) — […]
Pr Newswire
4DMT Advances Leadership in Large Market Ophthalmology with Senior Management Hires and Formation of Ophthalmology Advisory Board
05
Aug
Aug
Dhaval Desai, PharmD, named as Chief Development Officer; will oversee late-stage Product Development, Medical Affairs, Scientific Communications, Regulatory and Quality operations; most recently SVP & Chief Development Officer at Iveric Bio where he led development and approval of IZERVAY Christopher Simms named as Chief Commercial Officer, effective September 25, 2024; will oversee Pre-commercial and Commercial […]
Pr Newswire
Daxor Expands To Three New Facilities As Blood Volume Analysis Technology Gains Momentum Nationwide
05
Aug
Aug
Daxor’s ezBVA Lab Service Spearheads Growth and Broader Market Adoption Oak Ridge, TN, Aug. 05, 2024 (GLOBE NEWSWIRE) — Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces the expansion of blood volume analysis (BVA) in three new facilities. Daxor’s ezBVA lab service is a state-of-the-art CLIA certified facility that […]
Stephen Doyle has more than 24 years of experience in the global pharmaceutical industry, including leadership positions with companies such as Sanofi Aventis and Boehringer Ingelheim. He was most recently Chief Business Officer at Aslan Pharmaceuticals. Mr Doyle brings extensive knowledge in leading negotiations for pharmaceutical assets across a range of deal types, licensing deals across […]